This is the protocol for a review and there is no abstract. The objectives are as follows:
Does early referral reduce all-cause mortality and hospitalisation, and improve quality of life, measured by the visual analogue scale and SF-36 (Caskey 2003). SF-36 and KDQoL are a validated tools for kidney diseases (Gentile 2003).
Does early referral delay onset of RRT?
Is there any objective evidence that early nephrological referral improves outcomes, for example, mortality, morbidity, psychosocial benefits, quality of life?
Are cardiovascular risk factors better addressed with combined nephrologist and primary care physician care?
If you can't find a tool you're looking for, please click the link at the top of the page to "Go to old article view". Alternatively, view our Knowledge Base articles for additional help. Your feedback is important to us, so please let us know if you have comments or ideas for improvement.